RMRP变体抑制了软骨-毛发低成形中细胞循环检查点通路
Jian Gao1, Junge Zheng1, Shiguo Chen1
1Laboratory of Molecular Medicine, Institute of Maternal and Child Medicine Research, Shenzhen Maternity and Child Healthcare Hospital, Shenzhen, Guangdong 518040, P.R. China.
Molecular medicine reports
|January 31, 2025
概括
软骨-毛发缺血症 (CHH) 与线粒体RNA处理核激素酶 (RMRP) 基因变异的新RNA成分有关. 这一发现扩大了CHH遗传原因,并揭示了RMRP.
科学领域:
- 遗传学和分子生物学
- 发展生物学 发展生物学
- 医学遗传学 医学遗传学
背景情况:
- 软骨-毛发缺血症 (CHH) 是一种自体逆性骨缺血症.
- CHH的遗传基础主要归因于线粒体RNA处理核糖核酶 (RMRP) 基因的RNA成分的变异.
- 导致CHH病变的精确分子机制尚不完全理解.
研究的目的:
- 确定与CHH相关的RMRP中的新型遗传变异.
- 研究RMRP变异在CHH中的分子途径和功能后果.
- 探索潜在的CHH治疗策略,如生长激素 (GH) 治疗.
主要方法:
- 整体外体测序和桑格测序用于检测和确认患者和家庭成员的RMRP变异.
- 分析了来自公共数据库 (EMBL-EBI ENA,ArrayExpress) 的基因表达特征数据.
- 发明性路径分析 (IPA) 用于识别与差异表达基因相关的丰富的正规路径和疾病/功能.
主要成果:
- 在CHH患者中发现了RMRP (c.-21_ -2dup和c.197C>T) 的新型化合物异构变体.
- 在2年的随访期间,生长激素 (GH) 治疗对身高产生了积极影响.
- IPA发现"细胞循环检查点"是最突出的途径,与癌症,免疫,发育和呼吸系统疾病有关.
- 综合性分析表明,RMRP通过TP53调节下游目标,抑制细胞周期检查点并激活生长失败表型.
结论:
- 新型RMRP变异扩大了已知的CHH遗传病因,需要从无形质形成症中进行临床分化.
- 这项研究为CHH的分子机制提供了新的见解,突出了RMRP在调节细胞周期检查点中的作用.
- 研究结果表明,RMRP变体通过破坏正常生长和发育途径,导致CHH.
相关概念视频
Negative Regulator Molecules
35.1K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.1K
DNA Damage can Stall the Cell Cycle
9.0K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.0K
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Inhibition of Cdk Activity
4.6K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Positive Regulator Molecules
5.3K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
5.3K


